ACE2 and infection: SARS-CoV-2 utilizes the entry receptor angiotensin-converting enzyme-2 (ACE2), with priming of the serine protease transmembrane serine protease 2 (TMPRSS2) to gain entry into the respiratory mucosa and cause active infection.13